Palleiko Benjamin L bought KALV

January 16, 2026 · Form 4 insider transaction

Palleiko Benjamin L bought 325,000 shares of KalVista Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
325,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2026
Filing dateJanuary 21, 2026
Shares owned after325,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.; 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 22, 2026, for so long as grantee's Service (as defined in the Plan) does not terminate.

View the original Form 4 on SEC EDGAR